Benzinga | Oct 4, 2021 11:53AM EDT

JonesTrading Initiates Coverage On Amryt Pharma with Buy Rating, Announces Price Target of $45

JonesTrading initiates coverage on Amryt Pharma (NASDAQ:AMYT) with a Buy rating and announces Price Target of $45.